Share

All Updates

June 3, 2024
Pennsylvania

Today, the House Insurance Committee voted to improve Pennsylvanians’ access to biomarker testing, advancing House Bill 1754 out of committee unanimously. Championed by Representatives Kyle Mullins and Minority Leader Bryan Cutler, the proposal would ensure biomarker testing is a covered benefit in Pennsylvania-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it would provide a benefit to patients. Advocates now look to the full House to favorably advance House Bill 1754 to the Senate.

June 3, 2024
New York

Ahead of state lawmakers’ adjournment for the summer, advocates with the American Cancer Society Cancer Action Network (ACS CAN) are calling for the passage of legislation improving access to paid family and medical leave.

June 3, 2024
New York

Ahead of state lawmakers’ adjournment for the summer, advocates with the American Cancer Society Cancer Action Network (ACS CAN) are calling for the passage of legislation improving access to paid family and medical leave.

May 30, 2024
Connecticut

Gov. Ned Lamont has signed into law S.B. 307 An Act Concerning Medicaid Coverage of Biomarker Testing . This legislation will increase Connecticut Medicaid (HUSKY Health) coverage of biomarker testing, a form of precision medicine that enables patients to receive treatments personalized to their specific disease.

May 30, 2024
Illinois

Historic Session Yields Comprehensive Support Measures for Cancer Care and Research

May 30, 2024
Illinois

Historic Session Yields Comprehensive Support Measures for Cancer Care and Research

May 25, 2024
Illinois

SPRINGFIELD, IL – Today, the state legislature passed House Bill 5405, improving access and diversity in clinical trials, which can be a game changer in the fight against cancer. The following is a statement from Ally Lopshire, government relations director for the American Cancer Society Cancer Action Network (ACS CAN)

May 25, 2024
Illinois

SPRINGFIELD, IL – Today, the state legislature passed House Bill 5405, improving access and diversity in clinical trials, which can be a game changer in the fight against cancer. The following is a statement from Ally Lopshire, government relations director for the American Cancer Society Cancer Action Network (ACS CAN)

May 23, 2024
Tennessee

NASHVILLE, Tenn. – Gov. Bill Lee signed HB 2954 /SB2883 this week, making Tennessee the sixth state in the U.S. to enhance coverage of prostate cancer screenings for high-risk men. The state’s “PSA Screening For HIM” bill eliminates costs for certain patients to get these lifesaving screenings, thus